Analyze Diet
Endocrinology1982; 110(4); 1430-1441; doi: 10.1210/endo-110-4-1430

Equine Cushing’s disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.

Abstract: No abstract available
Publication Date: 1982-04-01 PubMed ID: 6277607DOI: 10.1210/endo-110-4-1430Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • P.H.S.

Cite This Article

APA
Orth DN, Holscher MA, Wilson MG, Nicholson WE, Plue RE, Mount CD. (1982). Equine Cushing’s disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology, 110(4), 1430-1441. https://doi.org/10.1210/endo-110-4-1430

Publication

ISSN: 0013-7227
NlmUniqueID: 0375040
Country: United States
Language: English
Volume: 110
Issue: 4
Pages: 1430-1441

Researcher Affiliations

Orth, D N
    Holscher, M A
      Wilson, M G
        Nicholson, W E
          Plue, R E
            Mount, C D

              MeSH Terms

              • Adrenocorticotropic Hormone / blood
              • Animals
              • Arginine Vasopressin
              • Circadian Rhythm
              • Corticotropin-Like Intermediate Lobe Peptide
              • Cushing Syndrome / blood
              • Cushing Syndrome / veterinary
              • Dexamethasone
              • Dopamine / pharmacology
              • Endorphins / blood
              • Female
              • Glucose Tolerance Test
              • Horse Diseases / blood
              • Horses / blood
              • Hydrocortisone / blood
              • Insulin
              • Male
              • Melanocyte-Stimulating Hormones / blood
              • Peptide Fragments / blood
              • Pituitary Hormones, Anterior / blood
              • Pro-Opiomelanocortin
              • Protein Precursors / blood
              • Radioimmunoassay
              • beta-Endorphin

              Grant Funding

              • 5-R25-CA-19429 / NCI NIH HHS
              • 5-RO1-CA-11685 / NCI NIH HHS

              Citations

              This article has been cited 11 times.
              1. Stoeckle SD, Timmermann D, Merle R, Gehlen H. Plasma Amino Acids in Horses Suffering from Pituitary Pars Intermedia Dysfunction.. Animals (Basel) 2022 Nov 27;12(23).
                doi: 10.3390/ani12233315pubmed: 36496836google scholar: lookup
              2. Kirkwood NC, Hughes KJ, Stewart AJ. Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID).. Vet Sci 2022 Oct 17;9(10).
                doi: 10.3390/vetsci9100572pubmed: 36288186google scholar: lookup
              3. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet Sci 2022 Oct 10;9(10).
                doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
              4. Held F, Ekstrand C, Cvijovic M, Gabrielsson J, Jirstrand M. Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols.. J Pharmacokinet Pharmacodyn 2019 Feb;46(1):75-87.
                doi: 10.1007/s10928-018-09617-0pubmed: 30673914google scholar: lookup
              5. Morgan RA, Keen JA, Homer N, Nixon M, McKinnon-Garvin AM, Moses-Williams JA, Davis SR, Hadoke PWF, Walker BR. Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction.. Endocrinology 2018 Nov 1;159(11):3791-3800.
                doi: 10.1210/en.2018-00726pubmed: 30289445google scholar: lookup
              6. Carmalt JL, Mortazavi S, McOnie RC, Allen AL, Unniappan S. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.. PLoS One 2018;13(1):e0190796.
                doi: 10.1371/journal.pone.0190796pubmed: 29309431google scholar: lookup
              7. Carmalt JL, Waldner CL, Allen AL. Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.. Can J Vet Res 2017 Oct;81(4):261-269.
                pubmed: 29081583
              8. Azevedo MF, Xekouki P, Keil MF, Lange E, Patronas N, Stratakis CA. An unusual presentation of pediatric Cushing disease: recurrent corticotropinoma of the posterior pituitary lobe.. J Pediatr Endocrinol Metab 2010 Jun;23(6):607-12.
                doi: 10.1515/jpem.2010.100pubmed: 20662335google scholar: lookup
              9. Haritou SJ, Zylstra R, Ralli C, Turner S, Tortonese DJ. Seasonal changes in circadian peripheral plasma concentrations of melatonin, serotonin, dopamine and cortisol in aged horses with Cushing's disease under natural photoperiod.. J Neuroendocrinol 2008 Aug;20(8):988-96.
              10. Fazio E, Medica P, Aronica V, Grasso L, Ferlazzo A. Circulating beta-endorphin, adrenocorticotrophic hormone and cortisol levels of stallions before and after short road transport: stress effect of different distances.. Acta Vet Scand 2008 Mar 3;50(1):6.
                doi: 10.1186/1751-0147-50-6pubmed: 18315878google scholar: lookup
              11. T'Sjoen G, Defeyter I, Van De Saffele J, Rubens R, Vandeweghe M. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.. J Endocrinol Invest 2002 Feb;25(2):172-5.
                doi: 10.1007/BF03343983pubmed: 11929090google scholar: lookup